Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:36

Mismatch Repair

Overview
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 3-Hit Metabolic Signaling Model for Autism Spectrum Disorder: A Summary.

Autism research : official journal of the International Society for Autism Research·2026
Same author

Immunoglobulin G complexes from post-infectious ME/CFS, including post-COVID ME/CFS disrupt cellular energetics and alter inflammatory marker secretion.

Brain, behavior, & immunity - health·2026
Same author

A 3-hit metabolic signaling model for the core symptoms of autism spectrum disorder.

Mitochondrion·2025
Same author

A narrative review of potential therapies for the treatment of myocardial tissue in relation to heart failure.

Nucleosides, nucleotides & nucleic acids·2025
Same author

Epigenetic modulation of human neurobiological disorders: Lesch-Nyhan disease as a model disorder.

AIMS neuroscience·2025
Same author

Whole-genome bisulfite sequencing of cell-free DNA unveils age-dependent and ALS-associated methylation alterations.

Cell & bioscience·2025

Related Experiment Video

Updated: May 30, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Novel mutations in the human HPRT gene.

Khue Vu Nguyen1, Robert K Naviaux, Kacie K Paik

  • 1Department of Medicine, Biochemical Genetics and Metabolism, The Mitochondrial and Metabolic Disease Center, University of California, San Diego, School of Medicine, San Diego, California 92103-8467, USA. kvn006@ucsd.edu

Nucleosides, Nucleotides & Nucleic Acids
|July 26, 2011
PubMed
Summary

Five novel mutations in the hypoxanthine guanine phosphoribosyltransferase (HPRT) gene were identified in five male patients with Lesch-Nyhan Syndrome (LNS). These genetic variations contribute to diverse clinical presentations of HPRT-related disorders.

More Related Videos

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Targeted in Situ Mutagenesis of Histone Genes in Budding Yeast
08:48

Targeted in Situ Mutagenesis of Histone Genes in Budding Yeast

Published on: January 26, 2017

Related Experiment Videos

Last Updated: May 30, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Targeted in Situ Mutagenesis of Histone Genes in Budding Yeast
08:48

Targeted in Situ Mutagenesis of Histone Genes in Budding Yeast

Published on: January 26, 2017

Area of Science:

  • Genetics
  • Biochemistry
  • Molecular Biology

Background:

  • Lesch-Nyhan Syndrome (LNS) is an inherited disorder caused by mutations in the hypoxanthine guanine phosphoribosyltransferase (HPRT) gene.
  • HPRT is a purine salvage enzyme crucial for nucleotide metabolism.
  • Mutations in HPRT can lead to neurological dysfunction and hyperuricemia, presenting as LNS or HPRT-related gout.

Purpose of the Study:

  • To identify and characterize novel mutations in the HPRT gene.
  • To correlate specific HPRT mutations with distinct clinical phenotypes in patients with LNS.
  • To expand the understanding of the genetic basis of HPRT deficiency.

Main Methods:

  • Direct sequencing of the coding region of the HPRT gene.
  • Analysis of five unrelated male patients with clinical manifestations of LNS.
  • Identification of mutations through comparison with wild-type HPRT sequences.

Main Results:

  • Five novel, independent mutations in the HPRT gene were identified in five patients.
  • Mutations were located in different regions of the HPRT gene, including exon 2 and exon 7.
  • Specific mutations identified: c.133A > G (p.45R > G), c.35A > C (p.12D > A), c.88delG, c.530A > T (p.177D > V), and a splice site mutation c.318 + 1G > C (IVS3 + 1G > C).

Conclusions:

  • The identified novel HPRT mutations provide new insights into the genetic heterogeneity of LNS.
  • These mutations are associated with varied clinical phenotypes, underscoring the importance of precise genetic diagnosis.
  • Further research is warranted to understand the functional consequences of these mutations on HPRT enzyme activity and disease pathogenesis.